<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Treatment of distal deep vein thrombosis - Kirkilesis, G - 2020 | Cochrane Library</title> <meta content="Treatment of distal deep vein thrombosis - Kirkilesis, G - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013422.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Treatment of distal deep vein thrombosis - Kirkilesis, G - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013422.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013422.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Treatment of distal deep vein thrombosis" name="citation_title"/> <meta content="George Kirkilesis" name="citation_author"/> <meta content="University of Patras Medical School" name="citation_author_institution"/> <meta content="geokirkilessis@yahoo.gr" name="citation_author_email"/> <meta content="Stavros K Kakkos" name="citation_author"/> <meta content="University of Patras Medical School" name="citation_author_institution"/> <meta content="Colin Bicknell" name="citation_author"/> <meta content="Imperial College London" name="citation_author_institution"/> <meta content="Safa Salim" name="citation_author"/> <meta content="Imperial College Healthcare NHS Trust" name="citation_author_institution"/> <meta content="Kyriaki Kakavia" name="citation_author"/> <meta content="National and Kapodistrian University of Athens" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD013422.pub2" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/04/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013422.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013422.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013422.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticoagulants [adverse effects, *therapeutic use]; Drug Administration Schedule; Hemorrhage [chemically induced, epidemiology]; Leg [*blood supply]; Pulmonary Embolism [epidemiology, etiology]; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Time Factors; Venous Thromboembolism [complications, *therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013422.pub2&amp;doi=10.1002/14651858.CD013422.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ZDBB8PHY";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013422\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013422\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","ru","pt","ko","ms","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013422.pub2",title:"Treatment of distal deep vein thrombosis",firstPublishedDate:"Apr 9, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013422.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013422.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013422.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013422.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013422.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013422.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013422.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013422.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013422.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013422.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>23472 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013422.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-sec-0082"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-sec-0076"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/appendices#CD013422-sec-0087"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/table_n/CD013422StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/table_n/CD013422StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Treatment of distal deep vein thrombosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/information#CD013422-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>George Kirkilesis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/information#CD013422-cr-0003">Stavros K Kakkos</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/information#CD013422-cr-0004">Colin Bicknell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/information#CD013422-cr-0005">Safa Salim</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013422.pub2/information#CD013422-cr-0006">Kyriaki Kakavia</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/information/en#CD013422-sec-0090">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 April 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013422.pub2">https://doi.org/10.1002/14651858.CD013422.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013422-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013422-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013422-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013422-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013422-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013422-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD013422-abs-0005">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013422-abs-0001" lang="en"> <section id="CD013422-sec-0001"> <h3 class="title" id="CD013422-sec-0001">Background</h3> <p>The treatment of distal (below the knee) deep vein thrombosis (DVT) is not clearly established. Distal DVT can either be treated with anticoagulation, or monitored with close follow‐up to detect progression to the proximal veins (above the knee), which requires anticoagulation. Proponents of this monitoring strategy base their decision to withhold anticoagulation on the fact that progression is rare and most people can be spared from potential bleeding and other adverse effects of anticoagulation. </p> </section> <section id="CD013422-sec-0002"> <h3 class="title" id="CD013422-sec-0002">Objectives</h3> <p>To assess the effects of different treatment interventions for people with distal (below the knee) deep vein thrombosis (DVT). </p> </section> <section id="CD013422-sec-0003"> <h3 class="title" id="CD013422-sec-0003">Search methods</h3> <p>The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase and CINAHL databases and World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 12 February 2019. We also undertook reference checking to identify additional studies. </p> </section> <section id="CD013422-sec-0004"> <h3 class="title" id="CD013422-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) for the treatment of distal DVT.</p> </section> <section id="CD013422-sec-0005"> <h3 class="title" id="CD013422-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected trials and extracted data. We resolved disagreements by discussion. Primary outcomes of interest were recurrence of venous thromboembolism (VTE), DVT and major bleeding and follow up ranged from three months to two years. We performed fixed‐effect model meta‐analyses with risk ratio (RRs) and 95% confidence intervals (CIs). We assessed the certainty of the evidence using GRADE. </p> </section> <section id="CD013422-sec-0006"> <h3 class="title" id="CD013422-sec-0006">Main results</h3> <p>We identified eight RCTs reporting on 1239 participants. Five trials randomised participants to anticoagulation for up to three months versus no anticoagulation. Three trials compared anticoagulation treatment for different time periods. </p> <p><b>Anticoagulant compared to no intervention or placebo for distal DVT treatment</b> </p> <p>Anticoagulation with a vitamin K antagonist (VKA) reduced the risk of recurrent VTE during follow‐up compared with participants receiving no anticoagulation (RR 0.34, 95% CI 0.15 to 0.77; 5 studies, 496 participants; I<sup>2</sup> = 3%; high‐certainty evidence), and reduced the risk of recurrence of DVT (RR 0.25, 95% CI 0.10 to 0.67; 5 studies, 496 participants; I<sup>2</sup> = 0%; high‐certainty evidence). There was no clear effect on risk of pulmonary embolism (PE) (RR 0.81, 95% CI 0.18 to 3.59; 4 studies, 480 participants; I<sup>2</sup> = 0%; low‐certainty evidence). There was little to no difference in major bleeding with anticoagulation compared to placebo (RR 0.76, 95% CI 0.13 to 4.62; 4 studies, 480 participants; I<sup>2</sup> = 26%; low‐certainty evidence). There was an increase in clinically relevant non‐major bleeding events in the group treated with anticoagulants (RR 3.34, 95% CI 1.07 to 10.46; 2 studies, 322 participants; I<sup>2</sup> = 0%; high‐certainty evidence). There was one death, not related to PE or major bleeding, in the anticoagulation group. </p> <p><b>Anticoagulation for three months or more compared to anticoagulation for six weeks for distal DVT treatment</b> </p> <p>Three RCTs of 736 participants compared three or more months of anticoagulation with six weeks of anticoagulation. Anticoagulation with a VKA for three months or more reduced the incidence of recurrent VTE to 5.8% compared with 13.9% in participants treated for six weeks (RR 0.42, 95% CI 0.26 to 0.68; 3 studies, 736 participants; I<sup>2</sup> = 50%; high‐certainty evidence). The risk for recurrence of DVT was also reduced (RR 0.32, 95% CI 0.16 to 0.64; 2 studies, 389 participants; I<sup>2</sup> = 48%; high‐certainty evidence), but there was probably little or no difference in PE (RR 1.05, 95% CI 0.19 to 5.88; 2 studies, 389 participants; I<sup>2</sup> = 0%; low‐certainty evidence). There was no clear difference in major bleeding events (RR 3.42, 95% CI 0.36 to 32.35; 2 studies, 389 participants; I<sup>2</sup> = 0%; low‐certainty evidence) or clinically relevant non‐major bleeding events (RR 1.76, 95% CI 0.90 to 3.42; 2 studies, 389 participants; I<sup>2</sup> = 1%; low‐certainty evidence) between three months or more of treatment and six weeks of treatment. There were no reports for overall mortality or PE and major bleeding‐related deaths. </p> </section> <section id="CD013422-sec-0007"> <h3 class="title" id="CD013422-sec-0007">Authors' conclusions</h3> <p>Our review found a benefit for people with distal DVT treated with anticoagulation therapy using VKA with little or no difference in major bleeding events although there was an increase in clinically relevant non‐major bleeding when compared to no intervention or placebo. The small number of participants in this meta‐analysis and strength of evidence prompts a call for more research regarding the treatment of distal DVT. RCTs comparing different treatments and different treatment periods with placebo or compression therapy, are required. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013422-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013422-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013422-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013422-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013422-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013422-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013422-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD013422-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD013422-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013422-abs-0003">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013422-abs-0002" lang="en"> <h3>Treatment of below‐the‐knee deep vein thrombosis</h3> <p><b>Background</b> </p> <p>Venous thromboembolism (VTE) is a condition in which a blood clot forms in a vein, most commonly in the deep veins of the legs or pelvis. This is known as deep vein thrombosis, or DVT. The blood clot can dislodge and travel in the blood, particularly to the pulmonary arteries. This is known as pulmonary embolism, or PE. The term VTE includes both DVT and PE. </p> <p>Distal DVT (also known as isolated distal DVT, calf DVT or below‐the‐knee DVT) occurs when the blood clot develops inside the leg veins (below the knee). The extension of the clot in proximal (above the knee) veins and the migration of a clot to the lungs (PE) are the most common complications. The best treatment of distal DVT is not clearly established. Distal DVT can either be treated with anticoagulation (medicines that help prevent blood clots), with or without additional use of compression stockings, or no medications can be given, and monitoring with repeat ultrasounds can be performed to see if the clots grow, which requires anticoagulation. The main side effect of anticoagulation medication is the increased risk of bleeding. </p> <p><b>Study characteristics and key results</b> </p> <p>We identified eight randomised controlled trials (clinical studies where people are randomly put into one of two or more treatment groups) reporting on 1239 participants. Five of these trials randomised participants to anticoagulation for up to three months compared with no anticoagulation. Three trials compared anticoagulation treatment for different time periods. </p> <p>Our review demonstrated that in participants with distal DVT compared with no anticoagulation or placebo (pretend treatment), anticoagulation reduced the risk of recurrence of VTE. There were similar results for the recurrence of DVT, while there was no clear effect on risk of PE. This benefit was seen at the expense of an increase in clinically relevant non‐major bleeding, but not major bleeding. </p> <p>In a direct comparison of treatment duration, anticoagulation for three months or more was superior to a shorter course lasting up to six weeks, showing a reduced risk of recurrence of VTE and DVT with no clear difference in major bleeding and clinically relevant non‐major bleeding. </p> <p><b>Reliability of the evidence</b> </p> <p>For the comparison anticoagulation versus no anticoagulation or placebo, the reliability of the evidence was high for recurrence of VTE, DVT, and clinically relevant non‐major bleeding, and low for PE and major bleeding. For the comparison anticoagulation for three months or more versus six weeks, the reliability of the evidence was high for recurrence of VTE and DVT; and low for PE, major bleeding and clinically relevant non‐major bleeding, The reliability of the evidence was downgraded because of variation (or imprecision) of the results due to small numbers of events. </p> <p><b>Conclusion</b> </p> <p>Our review found a benefit for people with distal DVT treated with anticoagulation therapy with little or no clear difference in major bleeding events, although there was an increase in clinically relevant non‐major bleeding when compared with no treatment or placebo. The small number of participants in this meta‐analysis and strength of evidence suggests more research regarding the treatment of distal DVT is needed. Randomised controlled trials comparing different treatments and different treatment periods with placebo or compression therapy are required. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013422-sec-0082" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013422-sec-0082"></div> <h3 class="title" id="CD013422-sec-0083">Implications for practice</h3> <section id="CD013422-sec-0083"> <p>Our review suggests a benefit for people with distal deep vein thrombosis (DVT) treated with anticoagulation therapy using VKA with little or no difference in major bleeding although there was an increase in clinically relevant non‐major bleeding when compared with no intervention or placebo. This evidence may be used in daily practice for treatment of distal DVT and influence decisions made in guidelines for treatment of DVT, considering the certainty of evidence included in this review. </p> </section> <h3 class="title" id="CD013422-sec-0084">Implications for research</h3> <section id="CD013422-sec-0084"> <p>The small number of participants of this review prompts for more extended research in distal DVT. More randomised control trials comparing different treatments and different treatment periods with placebo or compression therapy are required to support these results. An interesting endpoint for future randomised control trials is the discrimination of symptomatic or asymptomatic recurrence of DVT or venous thromboembolism. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013422-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013422-sec-0008"></div> <div class="table" id="CD013422-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Anticoagulant compared to no intervention or placebo for distal deep vein thrombosis treatment</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Anticoagulant compared to no intervention or placebo for distal DVT treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with distal DVT </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> anticoagulant </p> <p><b>Comparison:</b> no intervention or placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention or placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with anticoagulant</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence of VTE</b> </p> <p>(follow‐up: 3 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.34</b><br/> (0.15 to 0.77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>496<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕</p> <p><b>High</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1000<br/> (14 to 70) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Major bleeding</b><br/> (follow‐up: 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.76</b><br/> (0.13 to 4.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>480<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>8 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000</p> <p>(1 to 38)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence of DVT</b> </p> <p>(follow‐up: 3 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.25</b><br/> (0.10 to 0.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>496<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕</p> <p><b>High</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>79 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000<br/> (8 to 53) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>PE</b> </p> <p>(follow‐up: 3 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.81</b><br/> (0.18 to 3.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>480<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000<br/> (2 to 44) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinically relevant non‐major bleeding</b> </p> <p>(follow‐up: 3 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.34</b><br/> (1.07 to 10.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>322<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕</p> <p><b>High</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>61 per 1000<br/> (19 to 190) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Overall mortality</b><br/> (follow‐up: 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.2</b> </p> <p>(0.13 to 77.69)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>430</p> <p>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 death reported in the anticoagulant group. 0 deaths reported in the no intervention or placebo group. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality related to PE</b><br/> (follow‐up: 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>430</p> <p>(3 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 PE‐related deaths reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DVT:</b> deep vein thrombosis; <b>PE:</b> pulmonary embolism; <b>RR:</b> risk ratio; <b>VTE:</b> venous thromboembolism. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level as total number of events was fewer than 300.<br/> <sup>b</sup>Upgraded one level due to large treatment effect.<br/> <sup>c</sup>Downgraded two levels for imprecision due to very few events and 95% CIs include both appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013422-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Anticoagulation for three months or more compared to anticoagulation for six weeks for distal deep vein thrombosis treatment</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Anticoagulation for 3 months or more compared to anticoagulation for 6 weeks for distal DVT treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with distal DVT </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> VKA for ≥ 3 months </p> <p><b>Comparison:</b> VKA for 6 weeks </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with anticoagulation for 6 weeks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with anticoagulation for ≥ 3 months</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence of VTE</b> </p> <p>(follow‐up: 16 weeks to 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.42</b><br/> (0.26 to 0.68) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>736<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕</p> <p><b>High</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>135 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57 per 1000<br/> (35 to 92) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Major bleeding</b> </p> <p>(follow‐up: 16 weeks to 15 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.42</b><br/> (0.36 to 32.35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>389<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000<br/> (2 to 161) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence of DVT</b> </p> <p>(follow‐up: 16 weeks to 15 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.32</b><br/> (0.16 to 0.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>389<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕</p> <p><b>High</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>144 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 1000<br/> (23 to 92) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>PE</b> </p> <p>(follow‐up: 16 weeks to 15 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.05</b><br/> (0.19 to 5.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>389<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000<br/> (2 to 59) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinically relevant non‐major bleeding</b> </p> <p>(follow‐up: 16 weeks to 15 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.76</b><br/> (0.90 to 3.42) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>389<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>60 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105 per 1000<br/> (54 to 204) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The included studies did not report on overall mortality.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality related to PE</b> </p> <p>(follow‐up: 15 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>197</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 included study reported there were no cases of death from PE.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DVT:</b> deep vein thrombosis; <b>PE:</b> pulmonary embolism; <b>RR:</b> risk ratio; <b>VTE:</b> venous thromboembolism. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level as total number of events was fewer than 300.<br/> <sup>b</sup>Upgraded one level due to large treatment effect.<br/> <sup>c</sup>Downgraded two levels for imprecision due to very few events and 95% CIs include both appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013422-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013422-sec-0009"></div> <section id="CD013422-sec-0010"> <h3 class="title" id="CD013422-sec-0010">Description of the condition</h3> <p>Venous thromboembolism (VTE) is the obstruction of any deep vein by a blood clot or the embolism of pulmonary arteries after thrombus migration. The pathophysiology of venous thromboses are described by Virchow's Triad as hypercoagulability, haemodynamic changes (as stasis or turbulence) and endothelial injury. VTE is comprised of deep vein thrombosis (DVT) or pulmonary embolism (PE), or both, and can occur spontaneously. The incidence of VTE in mostly white populations is between 100 per 100,000 person‐years and 200 per 100,000 person‐years (<a href="./references#CD013422-bbs2-0040" title="HeitJA . Epidemiology of venous thromboembolism. Nature Reviews Cardiology2015;12:464‐74. [DOI: 10.1038/nrcardio.2015.83] ">Heit 2015</a>; <a href="./references#CD013422-bbs2-0060" title="WhiteRH . The epidemiology of venous thromboembolism. Circulation2003;107(23 Suppl 1):I‐4‐I‐8. ">White 2003</a>). Of these, it is estimated that 45 per 100,000 person‐years to 117 per 100,000 person‐years are due to DVT (without PE) and 29 per 100,000 person‐years to 78 per 100,000 person‐years are due to PE (with or without DVT) (<a href="./references#CD013422-bbs2-0040" title="HeitJA . Epidemiology of venous thromboembolism. Nature Reviews Cardiology2015;12:464‐74. [DOI: 10.1038/nrcardio.2015.83] ">Heit 2015</a>). After anticoagulant discontinuation, recurrent VTE occurs in approximately 7.4% of people in one year, rising to 30.4% of people in 10 years (<a href="./references#CD013422-bbs2-0032" title="CushmanM . Epidemiology and risk factors for venous thrombosis. Seminars in Hematology2007;44(2):62‐9. ">Cushman 2007</a>; <a href="./references#CD013422-bbs2-0040" title="HeitJA . Epidemiology of venous thromboembolism. Nature Reviews Cardiology2015;12:464‐74. [DOI: 10.1038/nrcardio.2015.83] ">Heit 2015</a>; <a href="./references#CD013422-bbs2-0060" title="WhiteRH . The epidemiology of venous thromboembolism. Circulation2003;107(23 Suppl 1):I‐4‐I‐8. ">White 2003</a>). There are many risk factors for VTE, including periods of inactivity, dehydration, hospitalisation, trauma, surgery, clotting disorders and previous thrombosis, superficial vein thrombosis, pregnancy, oral combined hormonal contraceptives, malignancy, obesity, smoking and advancing age (<a href="./references#CD013422-bbs2-0029" title="AndersonFA , SpencerFA . Risk factors for venous thromboembolism. Circulation2003;107(23 Suppl 1):I‐9. ">Anderson 2003</a>; <a href="./references#CD013422-bbs2-0052" title="National Institute for Health and Care Excellence. Venous thromboembolism in over 16s: reducing the risk of hospital‐acquired deep vein thrombosis or pulmonary embolism (NG89). nice.org.uk/guidance/ng89(accessed August 2018). ">NICE 2018</a>). </p> <p>DVT describes the formation of thrombus in the deep veins in the legs, and can be divided into three types: </p> <p> <ul id="CD013422-list-0001"> <li> <p>distal DVT (also known as isolated distal DVT, calf DVT or below the knee DVT), involving the infrapopliteal venous system; </p> </li> <li> <p>femoropopliteal DVT, involving the proximal leg veins up to the inguinal ligament; and </p> </li> <li> <p>iliofemoral DVT involving proximal DVT that extends above the inguinal ligament.</p> </li> </ul> </p> <p>DVT is also sometimes categorised as provoked or unprovoked, that is, the DVT is caused by a known risk factor or not. Risk factors may be transient or persistent and the presence of risk factors and the type of risk factor influence the risk of recurrent VTE. </p> <p>DVT can also occur in the upper extremities (arms) but this is not the focus of this Cochrane Review and has been addressed in <a href="./references#CD013422-bbs2-0034" title="FeinbergJ , NielsenEE , JakobsenJC . Thrombolysis for acute upper extremity deep vein thrombosis. Cochrane Database of Systematic Reviews2017, Issue 12. [DOI: 10.1002/14651858.CD012175.pub2] ">Feinberg 2017</a>. </p> <p>Clinical presentation of DVT of the lower limbs may be associated with localised pain, swelling and erythema, and the later occurrence of post‐thrombotic syndrome (PTS) (leg pain, tenderness, leg fatigue, persistent swelling, erythema, pigmentation or ulceration). Distal DVT is a common form of DVT but the precise incidence of distal DVT is unknown. It is estimated that it affects 0.1% of people per year (48 per 100,000) and represents about one‐third to one‐half of lower extremity DVT (<a href="./references#CD013422-bbs2-0045" title="KesiemeE , KesiemeC , JebbinN , IrekpitaE , DongoA . Deep vein thrombosis: a clinical review. Journal of Blood Medicine2011;2:59‐69. [DOI: 10.2147/JBM.S19009] ">Kesieme 2011</a>). Distal DVT, particularly if left untreated, may recur or extend to the proximal veins, so increasing the risk for complications, including PE and PTS. Although rare, symptomatic PE can present as a complication of isolated distal DVT, with shortness of breath, pain on inspiration, tachycardia and right heart overload. If untreated, it can lead to circulatory collapse and death. After anticoagulation treatment there is a lower annualised incidence of VTE recurrence in people with isolated DVT compared with people with proximal DVT, but a similar incidence of PE recurrence (<a href="./references#CD013422-bbs2-0037" title="GalanaudJP , SevestreMA , GentyC , KahnSR , PernodG , RollandC , et al. Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. Journal of Thrombosis and Haemostasis2014;12(4):436‐43. [DOI: doi.org/10.1111/jth.12512] ">Galanaud 2014</a>). </p> <p>The standard treatment for VTE is anticoagulation therapy (<a href="./references#CD013422-bbs2-0044" title="KearonC , AklEA , OrnelasJ , BlaivasA , JimenezD , BounameauxH , et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest2016;149(2):315‐52. ">Kearon 2016</a>), which aims to interrupt the extension of the thrombus in proximal veins and reduce the risk for VTE recurrence (as DVT or PE). Anticoagulant drugs have the risk of bleeding as a complication of the treatment. The severity of bleeding is a reason for discontinuing the treatment and major bleeding episodes mostly require transfusion, endoscopic or angiographic intervention or surgery. Some major bleedings are fatal, and people with comorbidities are more prone to bleedings and most often interrupt the treatment (<a href="./references#CD013422-bbs2-0033" title="DiNisioM , AgenoW , RutjesAW , PapAF , BüllerHR . Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists. Thrombosis and Haemostasis2016;115(2):424‐32. [DOI: dx.doi.org/10.1160/TH15‐06‐0474] ">Di Nisio 2016</a>). </p> </section> <section id="CD013422-sec-0011"> <h3 class="title" id="CD013422-sec-0011">Description of the intervention</h3> <p>Clinical guidelines provide recommendations for treatment of DVT and VTE in different settings (<a href="./references#CD013422-bbs2-0044" title="KearonC , AklEA , OrnelasJ , BlaivasA , JimenezD , BounameauxH , et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest2016;149(2):315‐52. ">Kearon 2016</a>; <a href="./references#CD013422-bbs2-0051" title="National Institute for Health and Care Excellence. Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. nice.org.uk/guidance/cg144(accessed September 2015). ">NICE 2012</a>; <a href="./references#CD013422-bbs2-0058" title="StreiffMB , AgnelliG , ConnorsJM , CrowtherM , EichingerS , LopesR . Guidance for the treatment of deep vein thrombosis and pulmonary embolism. Journal of Thrombosis and Thrombolysis2016;41(1):32‐67. [DOI: 10.1007/s11239‐015‐1317‐0] ">Streiff 2016</a>). In general, anticoagulation is the recommended treatment of choice. The recommended initial treatment is with either a direct oral anticoagulant (DOAC; with or without initial parenteral anticoagulation as indicated) or a parenteral anticoagulant in conjunction with a vitamin K antagonist (VKA). Long‐term therapy (usually anticoagulation for a minimum of three months) is indicated to treat acute VTE. Then extended‐duration anticoagulation, often referred to as 'indefinite therapy' when no anticipated stop date exists, may be used among select patients for the secondary prevention of thrombosis. In some cases of VTE associated with an increased risk for morbidity or mortality, initial thrombolysis may be appropriate (<a href="./references#CD013422-bbs2-0044" title="KearonC , AklEA , OrnelasJ , BlaivasA , JimenezD , BounameauxH , et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest2016;149(2):315‐52. ">Kearon 2016</a>; <a href="./references#CD013422-bbs2-0051" title="National Institute for Health and Care Excellence. Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. nice.org.uk/guidance/cg144(accessed September 2015). ">NICE 2012</a>; <a href="./references#CD013422-bbs2-0059" title="WatsonL , BroderickC , ArmonMP . Thrombolysis for acute deep vein thrombosis. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD002783.pub4] ">Watson 2016</a>). Evidence and guidance do not recommend using compression stockings routinely for the prevention of PTS (<a href="./references#CD013422-bbs2-0042" title="KahnSR , ShapiroS , WellsPS , RodgerMA , KovacsMJ , AndersonDR , et al. Compression stockings to prevent post‐thrombotic syndrome: a randomised placebo‐controlled trial. Lancet2014;383(9920):880‐8. ">Kahn 2014</a>; <a href="./references#CD013422-bbs2-0044" title="KearonC , AklEA , OrnelasJ , BlaivasA , JimenezD , BounameauxH , et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest2016;149(2):315‐52. ">Kearon 2016</a>). In people with VTE in whom anticoagulation is inappropriate, or in those who develop further pulmonary emboli despite adequate anticoagulation, temporary intravenous catheter filters can be placed to prevent further embolisation (<a href="./references#CD013422-bbs2-0051" title="National Institute for Health and Care Excellence. Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. nice.org.uk/guidance/cg144(accessed September 2015). ">NICE 2012</a>). </p> <p>The best treatment for people with distal DVT is not clearly established. Distal DVT can be treated with anticoagulation, for example, a form of heparin or fondaparinux transitioned to a VKA, a low molecular weight heparin (LMWH) or a DOAC. Distal DVT can also be managed expectantly with close follow‐up to detect progression to the proximal veins requiring anticoagulation. Proponents of this strategy base their decision to withhold anticoagulation on the fact that progression is rare and most people can be spared from potential bleeding and other adverse effects of anticoagulation. </p> <p>To date, only a limited number of studies have reported on treatment of distal DVT using VKAs (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>), and some on LMWHs such as nadroparin (<a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). The CACTUS trial reported that anticoagulation with "nadroparin was not superior to placebo in reducing the risk of proximal extension or venous thromboembolic events in low‐risk outpatients with symptomatic calf DVT, but did increase the risk of bleeding" (<a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>). However, in one systematic review of randomised controlled trials (RCTs) and cohort studies, <a href="./references#CD013422-bbs2-0048" title="LimMS , AriyarajahA , OldmeadowC , HallA , EnjetiAK . A systematic review and meta‐analysis comparing anticoagulation versus no anticoagulation and shorter versus longer duration of anticoagulation for treatment of isolated distal deep vein thrombosis. Seminars in Thrombosis and Hemostasis2017;43(8):836‐48. [DOI: 10.1055/s‐0037‐1604085] ">Lim 2017</a> concluded that in a low‐risk population, the risk for recurrence of DVT or the extension of the distal DVT in a proximal deep vein was higher when a no treatment approach was performed compared with treatment with an anticoagulant drug. </p> </section> <section id="CD013422-sec-0012"> <h3 class="title" id="CD013422-sec-0012">How the intervention might work</h3> <p>Compression may improve venous function by preventing venous stasis, which in turn may prevent progression of the distal DVT to the proximal veins. </p> <p>Where no treatment is given, close observation with ultrasound is required for two weeks (<a href="./references#CD013422-bbs2-0035" title="FleckD , AlbadawiH , WallaceA , KnuttinenG , NaiduS , OkluR . Below‐knee deep vein thrombosis (DVT): diagnostic and treatment patterns. Cardiovascular Diagnosis and Therapy2017;7(Suppl 3):S134‐9. [DOI: 10.21037/cdt.2017.11.03] ">Fleck 2017</a>; <a href="./references#CD013422-bbs2-0043" title="KearonC , AklEA , ComerotaAJ , PrandoniP , BounameauxH , GoldhaberSZ , et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence‐based clinical practice guidelines. Chest2012;141 (2 Suppl):e419S‐e496S. [DOI: 10.1378/chest.11‐2301] ">Kearon 2012</a>; <a href="./references#CD013422-bbs2-0044" title="KearonC , AklEA , OrnelasJ , BlaivasA , JimenezD , BounameauxH , et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest2016;149(2):315‐52. ">Kearon 2016</a>), so anticoagulation can be started selectively in those few patients with documented proximal progression of the thrombus. </p> <p>Treatment with any anticoagulation limits the extension of the thrombus and decreases the risk for recurrence and complications. The anticoagulant effect of VKAs is achieved by decreasing the production of coagulation factors from the liver. LMWHs indirectly inhibit factors IIa and Xa; and synthetic pentasaccharides (including fondaparinux) are selective indirect factor Xa inhibitors. Among the new oral anticoagulants, dabigatran is a selective direct thrombin inhibitor, while rivaroxaban, apixaban and edoxaban are selective factor Xa inhibitors (<a href="./references#CD013422-bbs2-0045" title="KesiemeE , KesiemeC , JebbinN , IrekpitaE , DongoA . Deep vein thrombosis: a clinical review. Journal of Blood Medicine2011;2:59‐69. [DOI: 10.2147/JBM.S19009] ">Kesieme 2011</a>). </p> </section> <section id="CD013422-sec-0013"> <h3 class="title" id="CD013422-sec-0013">Why it is important to do this review</h3> <p>Distal DVT represents a separate issue from proximal DVT for several reasons, including the initial clinical decision to observe or treat; and if anticoagulation is given, there is debate on the appropriate treatment length. To date, existing Cochrane Reviews on this topic have not provided subgroup analyses to deal with these issues, as included RCTs either did not involve participants with isolated distal DVTs, or did not report distal DVT separately from proximal DVT (<a href="./references#CD013422-bbs2-0031" title="BrandaoGM , JunqueiraDR , RolloHA , SobreiraML . Pentasaccharides for the treatment of deep vein thrombosis. Cochrane Database of Systematic Reviews2017, Issue 12. [DOI: 10.1002/14651858.CD011782.pub2] ">Brandao 2017</a>; <a href="./references#CD013422-bbs2-0050" title="MiddeldorpS , PrinsMH , HuttenBA . Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. Cochrane Database of Systematic Reviews2014, Issue 8. [DOI: 10.1002/14651858.CD001367.pub3] ">Middeldorp 2014</a>; <a href="./references#CD013422-bbs2-0056" title="RobertsonL , KestevenP , McCaslinJE . Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD010956.pub2] ">Robertson 2015</a>; <a href="./references#CD013422-bbs2-0057" title="RobertsonL , StrachanJ . Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. Cochrane Database of Systematic Reviews2017, Issue 2. [DOI: 10.1002/14651858.CD006771.pub3] ">Robertson 2017</a>). Therefore, it is currently unclear which treatment for distal DVT is most effective and safe. Due to ongoing controversy, some people may be denied anticoagulation based on relatively small and possibly underpowered trials. There is a need for a standardised treatment approach for distal DVT in daily clinical practice. We aimed to identify existing RCT evidence for treatment of distal DVT and to determine the most effective and safe treatment options. Our review first determined if there is a need to anticoagulate; and second, what is the most appropriate length of anticoagulation. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013422-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013422-sec-0014"></div> <p>To assess the effects of different treatment interventions for people with distal (below the knee) deep vein thrombosis (DVT). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013422-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013422-sec-0015"></div> <section id="CD013422-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013422-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised control trials (RCTs).</p> </section> <section id="CD013422-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included adults (aged 18 years or older) with distal (also known as below the knee or calf) DVT. Diagnosis of a first or recurrent DVT was made using venography or ultrasonography. </p> </section> <section id="CD013422-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included studies which use anticoagulants (including LMWHs, DOACs, VKAs, synthetic pentasaccharides), or compression therapy for the treatment of distal DVT, of any dose or treatment duration. We planned to include the following comparisons: </p> <p> <ul id="CD013422-list-0002"> <li> <p>any anticoagulant versus no intervention or placebo;</p> </li> <li> <p>any anticoagulant versus any anticoagulant;</p> </li> <li> <p>any compression therapy versus no intervention or placebo;</p> </li> <li> <p>any anticoagulant versus any compression therapy;</p> </li> <li> <p>compression therapy versus no compression therapy.</p> </li> </ul> </p> <p>No intervention or placebo may have included serial ultrasound observations.</p> <p>We listed all treatment groups in the <a href="./references#CD013422-sec-0096" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD013422-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>Outcomes were measured at the end of the intervention and the follow‐up period, as reported by the individual studies, usually between three and six months from recruitment. We include long‐term results (one to two years), where available. </p> <section id="CD013422-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD013422-list-0003"> <li> <p>Recurrence of VTE: defined as DVT recurrence in the calf veins, or progression of DVT to proximal veins (e.g. popliteal or femoral vein) or PE, provided that these were objectively diagnosed with venography or ultrasonography for DVT and pulmonary angiography, computed tomography or V/Q scan for PE. We considered any episode of DVT after the first episode, including propagation of distal DVT, as recurrence. </p> </li> <li> <p>Major bleeding: defined as clinically overt and associated with a fall in haemoglobin level of 20 g/L or more; transfusion of two or more units of red cells; retroperitoneal, intracranial, occurred in a critical site, or contributed to death. </p> </li> </ul> </p> </section> <section id="CD013422-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD013422-list-0004"> <li> <p>Recurrence of DVT, which included DVT recurrence in the calf veins, progression of DVT to proximal veins (e.g. popliteal or femoral vein); objectively diagnosed with venography or ultrasonography. We considered any episode of DVT after the first episode, including propagation of distal DVT, as recurrence. </p> </li> <li> <p>PE: objectively diagnosed with pulmonary angiography, computed tomography or V/Q scan.</p> </li> <li> <p>Clinically relevant non‐major bleeding, defined as overt bleeding not meeting the criteria for major bleeding but associated with medical intervention, unscheduled contact with a physician, interruption or discontinuation of study treatment, or associated with any other discomfort such as pain or impairment of activities of daily life. </p> </li> <li> <p>Overall mortality.</p> </li> <li> <p>Mortality related to PE or major bleeding.</p> </li> <li> <p>Post‐thrombotic syndrome (PTS).</p> </li> <li> <p>Resolution of symptoms.</p> </li> </ul> </p> </section> </section> </section> <section id="CD013422-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013422-sec-0024"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Vascular Information Specialist conducted systematic searches of the following databases for RCTs and controlled clinical trials without language, publication year or publication status restrictions: </p> <p> <ul id="CD013422-list-0005"> <li> <p>the Cochrane Vascular Specialised Register via the Cochrane Register of Studies (CRS‐Web searched from inception to 12 February 2019); </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) Cochrane Register of Studies Online (CRSO 2019, Issue 1); </p> </li> <li> <p>MEDLINE (Ovid MEDLINE Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE) (1946 onwards) (searched from 1 January 2017 to 12 February 2019); </p> </li> <li> <p>Embase Ovid (from 1974 onwards) (searched from 1 January 2017 to 12 February 2019);</p> </li> <li> <p>CINAHL EBSCO (from 1982 onwards) (searched from 1 January 2017 to 12 February 2019).</p> </li> </ul> </p> <p>The Information Specialist modelled search strategies for other databases on the search strategy designed for MEDLINE. Where appropriate, they were combined with adaptations of the highly sensitive search strategy designed by Cochrane for identifying RCTs and controlled clinical trials (as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Chapter 6, <a href="./references#CD013422-bbs2-0046" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Lefebvre 2011</a>). Search strategies for major databases are provided in <a href="./appendices#CD013422-sec-0088">Appendix 1</a>. </p> <p>The Information Specialist searched the following trials registries on 12 February 2019: </p> <p> <ul id="CD013422-list-0006"> <li> <p>the World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/trialsearch" target="_blank">who.int/trialsearch</a>); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>). </p> </li> </ul> </p> </section> <section id="CD013422-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of relevant articles to identify additional trials.</p> </section> </section> <section id="CD013422-sec-0026"> <h3 class="title" id="CD013422-sec-0026">Data collection and analysis</h3> <section id="CD013422-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors (GIK, SS) independently screened titles and abstracts of retrieved studies for relevance. We retrieved full‐text articles of all potentially eligible studies. Two review authors (GIK, SS) independently reviewed each full‐text article for eligibility. Any discrepancy was resolved by discussion or by consulting a third review author (SKK). We illustrated the study selection process in a PRISMA diagram (<a href="./references#CD013422-bbs2-0047" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GotzschePC , IoannidisJP , et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine2009;6:e1000100. ">Liberati 2009</a>). We listed all articles excluded after full‐text assessment in the <a href="./references#CD013422-sec-0097" title="">Characteristics of excluded studies</a> table and provided the reasons for their exclusion. Where studies had multiple publications, we collated the reports of the same study so that each study, rather than each report, was the unit of interest for the review, and such studies had a single identifier with multiple references. </p> </section> <section id="CD013422-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (GIK, SS) independently extracted relevant data on primary and secondary outcomes and transfer the information to data collection sheets. We resolve discrepancies by consulting with a third review author (SKK) and transferred additional general information on each included study, including numbers, gender, mean age of participants, and types of interventions, to the <a href="./references#CD013422-sec-0096" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD013422-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (GIK, SS) independently assessed each included study for risk of bias according to the following criteria: random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective reporting (reporting bias) and other bias, as recommended by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013422-bbs2-0041" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from handbook.cochrane.org. ">Higgins 2011</a>). We judged all included studies as having low, high or unclear risk of bias based on these criteria. We resolved disagreements by discussion with a third review author (SKK). </p> </section> <section id="CD013422-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We used Review Manager 5 to calculate the measures of treatment effect (<a href="./references#CD013422-bbs2-0054" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We assessed dichotomous data by calculating risk ratios (RRs) with 95% confidence intervals (CIs). We assessed continuous data by calculating the mean difference (MD) and standard deviation (SD) with corresponding 95% CI. We used standardised mean differences (SMD) with 95% CIs to combine outcomes from trials that used different scales. </p> </section> <section id="CD013422-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>Each individual participant was the unit of analysis.</p> </section> <section id="CD013422-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We recorded missing and unclear data. If possible, we performed all analyses using an intention‐to‐treat approach, that is, we analysed all participants and their outcomes within the groups to which they were allocated, regardless of whether they received the intervention or were assessed for the outcome. If necessary, we contacted study authors to request missing data. </p> </section> <section id="CD013422-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed interstudy heterogeneity using a forest plot. We calculated Chi<sup>2</sup> and I<sup>2</sup> statistics to measure the amount of heterogeneity. I<sup>2</sup> values less than 50% indicate low heterogeneity, I<sup>2</sup> values between 50% and 75% indicate moderate heterogeneity, and I<sup>2</sup> values greater than 75% indicate significant heterogeneity (<a href="./references#CD013422-bbs2-0041" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from handbook.cochrane.org. ">Higgins 2011</a>). We performed subgroup analyses to explore sources of heterogeneity. </p> </section> <section id="CD013422-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to assess reporting bias by using funnel plots, when a meta‐analysis included more than 10 studies (<a href="./references#CD013422-bbs2-0041" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD013422-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We used a fixed‐effect model for meta‐analysis when we observed no or low heterogeneity. In cases of moderate/significant heterogeneity (I<sup>2</sup> greater than 50%), we planned to use a random‐effects model. If we had identified substantial clinical, methodological or statistical heterogeneity across included trials, we planned not to report pooled results from the meta‐analysis but instead use an alternative approach to data synthesis (<a href="./references#CD013422-bbs2-0049" title="McKenzieJE , BrennanSE . Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from training.cochrane.org/handbook. ">McKenzie 2019</a>). </p> </section> <section id="CD013422-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where possible and when sufficient data were available, we performed subgroup analysis by examining: </p> <p> <ul id="CD013422-list-0007"> <li> <p>different types of anticoagulants;</p> </li> <li> <p>different types of compression;</p> </li> <li> <p>treatment length (short‐term about six weeks, or long‐term, about three to six months) as suggested by previous research and the American College of Chest Physicians and the International Union of Angiology guidelines (<a href="./references#CD013422-bbs2-0044" title="KearonC , AklEA , OrnelasJ , BlaivasA , JimenezD , BounameauxH , et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest2016;149(2):315‐52. ">Kearon 2016</a>; <a href="./references#CD013422-bbs2-0053" title="NicolaidesAN , FareedJ , KakkarAK , ComerotaAJ , GoldhaberSZ , HullR , et al. Prevention and treatment of venous thromboembolism: international consensus statement. International Angiology2013;32(2):111‐260. ">Nicolaides 2013</a>); </p> </li> <li> <p>dose of anticoagulant;</p> </li> <li> <p>provoked or unprovoked DVT;</p> </li> <li> <p>number of thrombosed calf veins (one versus multiple).</p> </li> </ul> </p> </section> <section id="CD013422-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to carry out sensitivity analysis by excluding RCTs with a high risk for bias in any domain displayed in the 'Risk of bias' graph and repeat the analyses. </p> <section id="CD013422-sec-0038"> <h5 class="title">Summary of findings and assessment of certainty of the evidence</h5> <p>We prepared 'Summary of findings' tables using the GRADEpro Guideline Development Tool (<a href="http://www.gradepro.org" target="_blank">www.gradepro.org</a>), to present the main findings of the review (<a href="./references#CD013422-bbs2-0030" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490‐4. ">Atkins 2004</a>). The population consisted of people with distal DVT. We included the following outcomes that are considered essential for decision‐making in our 'Summary of findings' tables: </p> <p> <ul id="CD013422-list-0008"> <li> <p>recurrence of VTE;</p> </li> <li> <p>major bleeding;</p> </li> <li> <p>recurrence of DVT;</p> </li> <li> <p>PE;</p> </li> <li> <p>clinically relevant non‐major bleeding;</p> </li> <li> <p>overall mortality;</p> </li> <li> <p>mortality related to PE.</p> </li> </ul> </p> <p>We create one 'Summary of findings' table for each comparison considered to be of clinical relevance. We evaluated the certainty of the evidence using the GRADE approach (<a href="./references#CD013422-bbs2-0039" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 30 January 2019. Hamilton, ON: McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>). We assigned one of four levels of quality: high, moderate, low or very low, based on overall risk of bias, directness of the evidence, inconsistency of results, precision of the estimates and risk of publication bias as previously described (<a href="./references#CD013422-bbs2-0041" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from handbook.cochrane.org. ">Higgins 2011</a>). We explained the downgrading of the evidence in the footnotes. We did not stratify into risk groups or use external information for the assumed risk of the comparison group. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013422-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013422-sec-0039"></div> <section id="CD013422-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD013422-sec-0041"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD013422-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD013422-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013422-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>We identified eight studies (11 records) which met the inclusion criteria (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>; <a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>; <a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). We excluded 15 studies (15 records) (<a href="./references#CD013422-bbs2-0009" title="DentaliF , PegoraraA , BarcoS , diMinnoMN , MastroiacovoD , PomeroF , et al. Clinical course of isolated deep vein thrombosis in patients with active cancer: a multicenter cohort study. Journal of Thrombosis and Haemostasis2017;15(9):1757‐63. ">Dentali 2017</a>; <a href="./references#CD013422-bbs2-0010" title="DonadiniMP , DentaliF , PegoraroS , PomeroF , BrignoneC , GuastiL , et al. Long‐term recurrence of venous thromboembolism after short‐term treatment of symptomatic isolated distal deep vein thrombosis: a cohort study. Vascular Medicine2017;22(6):518‐24. ">Donadini 2017</a>; <a href="./references#CD013422-bbs2-0011" title="GalanaudJP , SevestreM‐A , PernodG , GentyC , RicheletS , KahnSR , et al. Long‐term outcomes of cancer‐related isolated distal deep vein thrombosis: the OPTIMEV study. Journal of Thrombosis and Haemostasis2017;15(5):907‐16. ">Galanaud 2017</a>; <a href="./references#CD013422-bbs2-0012" title="HoP , LimHY , ChuaCC , SleemanM , TaceyM , DonnanG , et al. Retrospective review on isolated distal deep vein thrombosis(IDDVT) – a benign entity or not?. Thrombosis Research2016;142:11‐6. ">Ho 2016</a>; <a href="./references#CD013422-bbs2-0013" title="LeizoroviczA , GoldhaberSZ , OlssonCG , CohenAT , WeitzJI , TurpieAG . Mortality is increased in patients with proximal, but not distal, deep vein thrombosis in medically ill patients entered in the PREVENT trial. Blood2003;102:165a. ">Leizorovicz 2003</a>; <a href="./references#CD013422-bbs2-0014" title="McBaneR , Bott‐KitslaarD , CasanegraA , FroehlingD , BartlettM , LenzC , et al. Rivaroxaban and apixaban for treatment of acute isolated calf deep vein thrombosis – a single center prospective study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):339. ">McBane 2018</a>; <a href="./references#CD013422-bbs2-0015" title="MusilD . Regression of deep venous thrombosis. Vnitrni Lekarstvi2000;46(1):16‐8. ">Musil 2000</a>; <a href="./references#CD013422-bbs2-0016" title="NCT00816920 . Natural history of isolated deep vein thrombosis of the calf (CALTHRO). clinicaltrials.gov/ct2/show/NCT00816920 (first received 5 January 2009). ">NCT00816920</a>; <a href="./references#CD013422-bbs2-0017" title="NCT01234064 . Graduated Compression Stockings (GCS) pilot substudy. clinicaltrials.gov/ct2/show/NCT01234064 (first received 4 November 2010). ">NCT01234064</a>; <a href="./references#CD013422-bbs2-0018" title="NCT01252420 . Two weeks of low molecular weight heparin for distal vein thrombosis (TWISTER). clinicaltrials.gov/ct2/show/NCT01252420 (first received 3 December 2010). ">NCT01252420</a>; <a href="./references#CD013422-bbs2-0019" title="NCT02746185 . Cancer associated thrombosis, a pilot treatment study using rivaroxaban (CASTA‐DIVA). clinicaltrials.gov/ct2/show/NCT02746185 (first received 21 April 2016). ">NCT02746185</a>; <a href="./references#CD013422-bbs2-0020" title="PegoraroS , DiNisioM , BarcoS , DiMinnoMN , MastroiacovoD , PomeroF , et al. Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study. Italian Journal of Medicine2016;10(Suppl 2):87. ">Pegoraro 2016</a>; <a href="./references#CD013422-bbs2-0021" title="SchulmanS , GranqvistSA , Juhlin‐DannfeltA , LocknerD . Long‐term sequelae of calf vein thrombosis treated with heparin or low‐dose streptokinase. Acta Medica Scandinavica1986;219(4):349‐57. ">Schulman 1986</a>; <a href="./references#CD013422-bbs2-0022" title="SchwarzT , SchmidtB , BeyerJ , SchellongSM . Therapy of isolated calf muscle vein thrombosis – results of a cohort study. Annals of Hematology2001;80(Suppl 1):A59. ">Schwarz 2001</a>; <a href="./references#CD013422-bbs2-0023" title="UtterGH , DhillonTS , SalcedoES , ShouldiceDJ , ReynoldsCL , HumphriesMD , et al. Therapeutic anticoagulation for isolated calf deep vein thrombosis. JAMA Surgery2016;151(9):e161770. ">Utter 2016</a>). In addition, we identified five ongoing studies (six records) (<a href="./references#CD013422-bbs2-0024" title="EUCTR2005‐004235‐21‐IT . Calf vein thrombosis 6 weeks‐treatment with LMWH vs warfarin. clinicaltrialsregister.eu/ctr‐search/trial/2005‐004235‐21/IT (Date first received 12 January 2007). GhirarduzziA , CamporeseG , SiragusaS , ImbertiD , BucheriniE , LandiniF , et al. A randomized, prospective, open‐label study on distal vein thrombosis (low‐molecular‐weight heparin vs. warfarin for 6 weeks): the todi study. Journal of Thrombosis and Haemostasis2009;7(Suppl 2):abstract no: PP‐WE‐403. ">EUCTR2005‐004235‐21‐IT</a>; <a href="./references#CD013422-bbs2-0025" title="NCT02722447 . Rivaroxaban for the treatment of symptomatic Isolated distal deep vein thrombosis (RIDTS). clinicaltrials.gov/ct2/show/NCT02722447 (first received 30 March 2016). ">NCT02722447</a>; <a href="./references#CD013422-bbs2-0026" title="NCT03368313 . Non‐elastic compression garment therapy versus control for deep vein thrombosis. clinicaltrials.gov/ct2/show/NCT03368313 (first received 11 December 2017). ">NCT03368313</a>; <a href="./references#CD013422-bbs2-0027" title="NCT03590743 . Calf deep vein thrombosis treatment trial. clinicaltrials.gov/ct2/show/NCT03590743 (first received 18 July 2018). ">NCT03590743</a>; <a href="./references#CD013422-bbs2-0028" title="UMIN000028105 . Evaluation of rivaroxaban for distal deep vein thrombosis – a single center, randomized, open‐label, assessor‐blind, parallel group, exploratory study. upload.umin.ac.jp/cgi‐open‐bin/ctr_e/ctr_view.cgi?recptno=R000032126 (first received 6 July 2017). ">UMIN000028105</a>). </p> </section> <section id="CD013422-sec-0042"> <h4 class="title">Included studies</h4> <p>We included eight studies (11 records) that met the inclusion criteria, reporting outcomes on 1239 participants (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>; <a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>; <a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). Three studies compared VKA treatment for six weeks versus 12 weeks or more (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>; <a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>). From the remaining five studies, three studies compared anticoagulants versus no intervention or placebo for three months (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>), and two studies compared anticoagulants versus placebo for up to six weeks (<a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). One trial that enrolled postoperative patients studied provoked DVT (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>), and two trials that enrolled outpatients with a first episode of isolated calf DVT studied unprovoked DVT (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>). The remaining five trials enrolled populations with provoked and unprovoked DVT without providing details for the subgroups (<a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>; <a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). See <a href="./references#CD013422-sec-0096" title="">Characteristics of included studies</a> table for further details. Two included studies had more than one reference (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>). </p> </section> <section id="CD013422-sec-0043"> <h4 class="title">Excluded studies</h4> <p>We excluded 15 studies (15 reports) due to: retrospective study design (<a href="./references#CD013422-bbs2-0009" title="DentaliF , PegoraraA , BarcoS , diMinnoMN , MastroiacovoD , PomeroF , et al. Clinical course of isolated deep vein thrombosis in patients with active cancer: a multicenter cohort study. Journal of Thrombosis and Haemostasis2017;15(9):1757‐63. ">Dentali 2017</a>; <a href="./references#CD013422-bbs2-0010" title="DonadiniMP , DentaliF , PegoraroS , PomeroF , BrignoneC , GuastiL , et al. Long‐term recurrence of venous thromboembolism after short‐term treatment of symptomatic isolated distal deep vein thrombosis: a cohort study. Vascular Medicine2017;22(6):518‐24. ">Donadini 2017</a>; <a href="./references#CD013422-bbs2-0012" title="HoP , LimHY , ChuaCC , SleemanM , TaceyM , DonnanG , et al. Retrospective review on isolated distal deep vein thrombosis(IDDVT) – a benign entity or not?. Thrombosis Research2016;142:11‐6. ">Ho 2016</a>; <a href="./references#CD013422-bbs2-0023" title="UtterGH , DhillonTS , SalcedoES , ShouldiceDJ , ReynoldsCL , HumphriesMD , et al. Therapeutic anticoagulation for isolated calf deep vein thrombosis. JAMA Surgery2016;151(9):e161770. ">Utter 2016</a>), prospective single‐arm study design (<a href="./references#CD013422-bbs2-0014" title="McBaneR , Bott‐KitslaarD , CasanegraA , FroehlingD , BartlettM , LenzC , et al. Rivaroxaban and apixaban for treatment of acute isolated calf deep vein thrombosis – a single center prospective study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):339. ">McBane 2018</a>), observational nature of the studies (<a href="./references#CD013422-bbs2-0011" title="GalanaudJP , SevestreM‐A , PernodG , GentyC , RicheletS , KahnSR , et al. Long‐term outcomes of cancer‐related isolated distal deep vein thrombosis: the OPTIMEV study. Journal of Thrombosis and Haemostasis2017;15(5):907‐16. ">Galanaud 2017</a>; <a href="./references#CD013422-bbs2-0016" title="NCT00816920 . Natural history of isolated deep vein thrombosis of the calf (CALTHRO). clinicaltrials.gov/ct2/show/NCT00816920 (first received 5 January 2009). ">NCT00816920</a>; <a href="./references#CD013422-bbs2-0018" title="NCT01252420 . Two weeks of low molecular weight heparin for distal vein thrombosis (TWISTER). clinicaltrials.gov/ct2/show/NCT01252420 (first received 3 December 2010). ">NCT01252420</a>), cohort studies (<a href="./references#CD013422-bbs2-0020" title="PegoraroS , DiNisioM , BarcoS , DiMinnoMN , MastroiacovoD , PomeroF , et al. Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study. Italian Journal of Medicine2016;10(Suppl 2):87. ">Pegoraro 2016</a>; <a href="./references#CD013422-bbs2-0022" title="SchwarzT , SchmidtB , BeyerJ , SchellongSM . Therapy of isolated calf muscle vein thrombosis – results of a cohort study. Annals of Hematology2001;80(Suppl 1):A59. ">Schwarz 2001</a>), prevention study (<a href="./references#CD013422-bbs2-0013" title="LeizoroviczA , GoldhaberSZ , OlssonCG , CohenAT , WeitzJI , TurpieAG . Mortality is increased in patients with proximal, but not distal, deep vein thrombosis in medically ill patients entered in the PREVENT trial. Blood2003;102:165a. ">Leizorovicz 2003</a>), testing of adjuvant thrombolysis (<a href="./references#CD013422-bbs2-0021" title="SchulmanS , GranqvistSA , Juhlin‐DannfeltA , LocknerD . Long‐term sequelae of calf vein thrombosis treated with heparin or low‐dose streptokinase. Acta Medica Scandinavica1986;219(4):349‐57. ">Schulman 1986</a>), ongoing prevention study (<a href="./references#CD013422-bbs2-0017" title="NCT01234064 . Graduated Compression Stockings (GCS) pilot substudy. clinicaltrials.gov/ct2/show/NCT01234064 (first received 4 November 2010). ">NCT01234064</a>), ongoing study for VTE in cancer (<a href="./references#CD013422-bbs2-0019" title="NCT02746185 . Cancer associated thrombosis, a pilot treatment study using rivaroxaban (CASTA‐DIVA). clinicaltrials.gov/ct2/show/NCT02746185 (first received 21 April 2016). ">NCT02746185</a>), and irrelevant (<a href="./references#CD013422-bbs2-0015" title="MusilD . Regression of deep venous thrombosis. Vnitrni Lekarstvi2000;46(1):16‐8. ">Musil 2000</a>). See <a href="./references#CD013422-sec-0097" title="">Characteristics of excluded studies</a> table for further details. </p> <section id="CD013422-sec-0044"> <h5 class="title">Ongoing studies</h5> <p>We identified five ongoing studies (<a href="./references#CD013422-bbs2-0024" title="EUCTR2005‐004235‐21‐IT . Calf vein thrombosis 6 weeks‐treatment with LMWH vs warfarin. clinicaltrialsregister.eu/ctr‐search/trial/2005‐004235‐21/IT (Date first received 12 January 2007). GhirarduzziA , CamporeseG , SiragusaS , ImbertiD , BucheriniE , LandiniF , et al. A randomized, prospective, open‐label study on distal vein thrombosis (low‐molecular‐weight heparin vs. warfarin for 6 weeks): the todi study. Journal of Thrombosis and Haemostasis2009;7(Suppl 2):abstract no: PP‐WE‐403. ">EUCTR2005‐004235‐21‐IT</a>; <a href="./references#CD013422-bbs2-0025" title="NCT02722447 . Rivaroxaban for the treatment of symptomatic Isolated distal deep vein thrombosis (RIDTS). clinicaltrials.gov/ct2/show/NCT02722447 (first received 30 March 2016). ">NCT02722447</a>; <a href="./references#CD013422-bbs2-0026" title="NCT03368313 . Non‐elastic compression garment therapy versus control for deep vein thrombosis. clinicaltrials.gov/ct2/show/NCT03368313 (first received 11 December 2017). ">NCT03368313</a>; <a href="./references#CD013422-bbs2-0027" title="NCT03590743 . Calf deep vein thrombosis treatment trial. clinicaltrials.gov/ct2/show/NCT03590743 (first received 18 July 2018). ">NCT03590743</a>; <a href="./references#CD013422-bbs2-0028" title="UMIN000028105 . Evaluation of rivaroxaban for distal deep vein thrombosis – a single center, randomized, open‐label, assessor‐blind, parallel group, exploratory study. upload.umin.ac.jp/cgi‐open‐bin/ctr_e/ctr_view.cgi?recptno=R000032126 (first received 6 July 2017). ">UMIN000028105</a>). See <a href="./references#CD013422-sec-0098" title="">Characteristics of ongoing studies</a> table for details of the ongoing studies. </p> </section> </section> </section> <section id="CD013422-sec-0045"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD013422-fig-0002">Figure 2</a>; <a href="#CD013422-fig-0003">Figure 3</a>. With the exception of performance bias, risk of bias domains were mostly low risk. </p> <div class="figure" id="CD013422-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013422-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD013422-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013422-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD013422-sec-0046"> <h4 class="title">Allocation</h4> <p>The randomisation method was unclear in two included RCTs (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>). </p> <p>We identified an unclear risk for allocation concealment in two included RCTs (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). </p> </section> <section id="CD013422-sec-0047"> <h4 class="title">Blinding</h4> <p>There was a high risk of performance bias in seven studies because of their open‐label randomisation (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>; <a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). Only one study was double‐blind and judged at low risk of performance bias (<a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>). </p> <p>One study reported outcome assessors were blinded (<a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>). The remaining studies did not blind outcome assessors, but we judged that the outcome measures reported by the studies this review (recurrent VTE, major bleeding, recurrent DVT, PE, clinically relevant non‐major bleeding, overall mortality and mortality related to PE and major bleeding) were not likely to be influenced by a lack of blinding of outcome assessors (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>; <a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). </p> </section> <section id="CD013422-sec-0048"> <h4 class="title">Incomplete outcome data</h4> <p>There was no incomplete outcome data reporting.</p> </section> <section id="CD013422-sec-0049"> <h4 class="title">Selective reporting</h4> <p>We identified no findings of selective reporting.</p> </section> <section id="CD013422-sec-0050"> <h4 class="title">Other potential sources of bias</h4> <p>There was no other potential source of bias.</p> </section> </section> <section id="CD013422-sec-0051"> <h3 class="title" id="CD013422-sec-0051">Effects of interventions</h3> <p>See: <a href="./full#CD013422-tbl-0001"><b>Summary of findings for the main comparison</b> Anticoagulant compared to no intervention or placebo for distal deep vein thrombosis treatment</a>; <a href="./full#CD013422-tbl-0002"><b>Summary of findings 2</b> Anticoagulation for three months or more compared to anticoagulation for six weeks for distal deep vein thrombosis treatment</a> </p> <p>Five RCTs compared anticoagulation therapy versus placebo (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>; <a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). Three RCTs compared treatment with VKAs for six weeks versus three months or more (<a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>). </p> <p>We found no relevant studies for compression therapy versus no intervention or placebo, anticoagulation versus compression therapy and compression therapy versus no compression therapy. </p> <section id="CD013422-sec-0052"> <h4 class="title">Any anticoagulant versus no intervention or placebo</h4> <p>Five RCTs compared anticoagulation therapy versus no intervention or placebo (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>; <a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). The studies used different forms of anticoagulation therapy: unfractionated heparin (<a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>), nadroparin (<a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>), and dalteparin (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>). </p> <section id="CD013422-sec-0053"> <h5 class="title">Primary outcomes</h5> <section id="CD013422-sec-0054"> <h6 class="title">Recurrence of venous thromboembolism</h6> <p>Five RCTs compared the effect of anticoagulation therapy versus no intervention or placebo, for the rates of recurrence of VTE: two RCTs for up to six weeks (RR 0.63, 95% CI 0.23 to 1.69; 2 studies, 359 participants; I<sup>2</sup> = 0%) (<a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>), and the remaining three RCTs for three months (RR 0.13, 95% CI 0.02 to 0.65; 3 studies, 137 participants; I<sup>2</sup> = 0%) (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>). The overall recurrence of VTE was lower in the anticoagulation group compared with the no intervention or placebo group (RR 0.34, 95% CI 0.15 to 0.77; 5 studies, 496 participants; I<sup>2</sup> = 3%; high‐certainty evidence). The test for subgroup differences showed no clear difference in recurrence of VTE between the subgroups anticoagulation for three months and anticoagulation for up to six weeks (P = 0.10) (<a href="./references#CD013422-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD013422-sec-0055"> <h6 class="title">Major bleeding</h6> <p>The meta‐analysis showed there was little to no difference in major bleeding events between anticoagulation therapy and no intervention or placebo (RR 0.76, 95% CI 0.13 to 4.62; 4 studies, 480 participants; I<sup>2</sup> = 26%; low‐certainty evidence; <a href="./references#CD013422-fig-0005" title="">Analysis 1.2</a>). </p> </section> </section> <section id="CD013422-sec-0056"> <h5 class="title">Secondary outcomes</h5> <section id="CD013422-sec-0057"> <h6 class="title">Recurrence of deep vein thrombosis</h6> <p>Results for recurrence of DVT showed a similar pattern to the results for recurrence of VTE. The overall recurrence of DVT was lower in the anticoagulation group compared with the no intervention or placebo group (RR 0.25, 95% CI 0.10 to 0.67; 5 studies, 496 participants; I<sup>2</sup> = 0%; high‐certainty evidence). The risk of recurrence of DVT in the subgroup of three months of anticoagulation was RR 0.09 (95% CI 0.01 to 0.71; 3 studies, 137 participants; I<sup>2</sup> = 0%) and the subgroup of up to six weeks of anticoagulation was RR 0.46 (95% CI 0.14 to 1.48; 2 studies, 359 participants; I<sup>2</sup> = 0%). The test for subgroup differences showed no clear difference in recurrence of DVT between the subgroups anticoagulation for three months and anticoagulation for up to six weeks (P = 0.18) (<a href="./references#CD013422-fig-0006" title="">Analysis 1.3</a>) </p> </section> <section id="CD013422-sec-0058"> <h6 class="title">Pulmonary embolism</h6> <p>We identified no clear difference in PE between the anticoagulation group compared with the no intervention or placebo group (RR 0.81, 95% CI 0.18 to 3.59; 4 studies, 480 participants; I<sup>2</sup> = 0%; low‐certainty evidence). The risk of PE in the subgroup of three months of anticoagulation was RR 0.37 (95% CI 0.04 to 3.42; 2 studies, 121 participants; I<sup>2</sup> = 0%) and in the subgroup up to six weeks of anticoagulation was RR 2.13 (95% CI 0.20 to 23.21; 2 studies, 359 participants; I<sup>2</sup> = 0%) (<a href="./references#CD013422-fig-0007" title="">Analysis 1.4</a>). </p> </section> <section id="CD013422-sec-0059"> <h6 class="title">Clinically relevant non‐major bleeding</h6> <p>Clinically relevant non‐major bleeding events were increased in the anticoagulation group compared with the no intervention or placebo group (RR 3.34, 95% CI 1.07 to 10.46; 2 studies, 322 participants; I<sup>2</sup> = 0%; high‐certainty evidence) (<a href="./references#CD013422-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD013422-sec-0060"> <h6 class="title">Overall mortality</h6> <p>Two studies reported no deaths in each of the study arms (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>), and one study reported one death from cancer in the nadroparin group (<a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>) (RR 3.20, 95% CI 0.13 to 77.69; 3 studies, 430 participants; I<sup>2</sup> = 0%; low‐certainty evidence). The remaining two studies did not report on mortality (<a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>) (<a href="./references#CD013422-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD013422-sec-0061"> <h6 class="title">Mortality related to pulmonary embolism or major bleeding</h6> <p>There were no cases of mortality related to PE or major bleeding in three studies (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). The remaining two studies did not report on mortality related to PE or major bleeding (<a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>). </p> </section> <section id="CD013422-sec-0062"> <h6 class="title">Post‐thrombotic syndrome</h6> <p>There were no reports of PTS in four studies included in the quantitative synthesis (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>). An additional publication of an included study (<a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>) reported on PTS (<a href="./references#CD013422-bbs2-0038" title="GalanaudJP , RighiniM , LeCollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the CACTUS‐PTS study. Research and Practice in Thrombosis and Haemostasis2018:rth2.12125. [DOI: 10.1002/rth2.12125] ">Galanaud 2018</a>). A minimum of one year after randomisation, participants were assessed for PTS. <a href="./references#CD013422-bbs2-0038" title="GalanaudJP , RighiniM , LeCollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the CACTUS‐PTS study. Research and Practice in Thrombosis and Haemostasis2018:rth2.12125. [DOI: 10.1002/rth2.12125] ">Galanaud 2018</a> reported PTS was present in 54/178 (29%) of participants and was moderate or severe in 13/54 (24%) of cases. There was no clear difference in rates of PTS in the nadroparin compared with the placebo group (RR 0.90, 95% CI 0.58 to 1.41; 1 study, 178 participants). </p> </section> <section id="CD013422-sec-0063"> <h6 class="title">Resolution of symptoms</h6> <p>There were no reports for resolution of symptoms in the studies included in the quantitative synthesis (<a href="./references#CD013422-bbs2-0002" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014;146(6):1468‐77. [DOI: 10.1378/chest.14‐0235] HornerD , HoggK , BodyR , NashMJ , Mackway‐JonesK . The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial. Trials2012;13:31. ">Horner 2014</a>; <a href="./references#CD013422-bbs2-0003" title="LagerstedtC , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long‐term anticoagulant treatment in symptomatic calf‐vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD013422-bbs2-0004" title="NielsenHK , HustedSE , KrusellLR , FastingH , CharlesP , HansenHH , et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thrombosis Research1994;73:215‐26. ">Nielsen 1994</a>; <a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>; <a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>), but one additional publication of an included study (<a href="./references#CD013422-bbs2-0006" title="GalanaudJ‐P , RighiniM , LecollenL , DouillardA , Robert‐EbadiH , PontalD , et al. Long‐term risk of post‐thrombotic syndrome after symptomatic distal deep‐vein thrombosis: the cactus‐PTS study. Research and Practice in Thrombosis and Haemostasis2018;2(Suppl 1):328‐9. [DOI: 10.1002/rth2.12125] RighiniM , GalanaudJP , GuenneguezH , BrisotD , DiardA , FaisseP , et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double‐blind, placebo‐controlled trial. Lancet Haematology2016;3(12):556‐62. [DOI: org/10.1016/S2352‐3026(16)30131‐4] RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJ‐M , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. ">Righini 2016</a>) did report on pain (<a href="./references#CD013422-bbs2-0055" title="RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJM , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. [DOI: 10.1111/jth.14387] ">Righini 2019</a>). <a href="./references#CD013422-bbs2-0055" title="RighiniM , Robert‐EbadiH , GlauserF , BlondonM , OuvryP , DiamandJM , et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. Journal of Thrombosis and Haemostasis2019;17(3):507‐10. [DOI: 10.1111/jth.14387] ">Righini 2019</a> reported no clear difference in the mean visual analogue pain scale (VAS) reduction between 106 participants treated with therapeutic nadroparin and 109 treated with placebo (after 1 week: 2.6 (SD 2.4) with nadroparin versus 2.3 (SD 2.0) with placebo; after 6 weeks: 4.4 (SD 2.8) with nadroparin versus 4.0 (SD 2.4) with placebo). The use of compression stockings was associated with a reduction in pain. </p> </section> </section> </section> <section id="CD013422-sec-0064"> <h4 class="title">Any anticoagulation versus any anticoagulation: three months or more of vitamin K antagonist versus six weeks of vitamin K antagonist </h4> <p>Three RCTs compared treatment with VKAs for three months or more versus six weeks (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>; <a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>). Stratified data for <a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a> were only available for recurrent VTE. </p> <section id="CD013422-sec-0065"> <h5 class="title">Primary outcomes</h5> <section id="CD013422-sec-0066"> <h6 class="title">Recurrence of venous thromboembolism</h6> <p>The incidence of recurrence of VTE was lower for the three months or more treatment period compared with the six weeks' treatment period (5.8% with 3 months or more versus 13.9% with 2 weeks; RR 0.42, 95% CI 0.26 to 0.68; 3 studies, 736 participants; I<sup>2</sup> = 50%; high‐certainty evidence) (<a href="./references#CD013422-fig-0013" title="">Analysis 2.1</a>). </p> </section> <section id="CD013422-sec-0067"> <h6 class="title">Major bleeding</h6> <p>There was no clear difference in major bleeding events between the three months or more and six weeks' treatment period (RR 3.42, 95% CI 0.36 to 32.35; 2 studies, 389 participants; I<sup>2</sup> = 0%; low‐certainty evidence) (<a href="./references#CD013422-fig-0014" title="">Analysis 2.2</a>). </p> </section> </section> <section id="CD013422-sec-0068"> <h5 class="title">Secondary outcomes</h5> <section id="CD013422-sec-0069"> <h6 class="title">Recurrence of deep vein thrombosis</h6> <p>The risk for recurrence of DVT was reduced for the three months or more treatment period compared with the six weeks' treatment period (RR 0.32, 95% CI 0.16 to 0.64; 2 studies, 389 participants; I<sup>2</sup> = 48%; high‐certainty evidence) (<a href="./references#CD013422-fig-0015" title="">Analysis 2.3</a>). </p> </section> <section id="CD013422-sec-0070"> <h6 class="title">Pulmonary embolism</h6> <p>There was probably little or no difference in recurrent PE between three months or more and six weeks' treatment period (RR 1.05, 95% CI 0.19 to 5.88; 2 studies, 389 participants; I<sup>2</sup> = 0%; low‐certainty evidence) (<a href="./references#CD013422-fig-0016" title="">Analysis 2.4</a>). </p> </section> <section id="CD013422-sec-0071"> <h6 class="title">Clinically relevant non‐major bleeding</h6> <p>There was no clear difference in clinically relevant non‐major bleeding events between the three months or more and the six weeks' treatment period (RR 1.76, 95% CI 0.90 to 3.42; 2 studies, 389 participants; I<sup>2</sup> = 1%; low‐certainty evidence) (<a href="./references#CD013422-fig-0017" title="">Analysis 2.5</a>). </p> </section> <section id="CD013422-sec-0072"> <h6 class="title">Overall mortality</h6> <p>There were no reports of overall mortality in included studies for people with distal DVT (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>; <a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>). </p> </section> <section id="CD013422-sec-0073"> <h6 class="title">Mortality related to pulmonary embolism or major bleeding</h6> <p>Two included studies reported no deaths related to major bleeding (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>). One study reported no cases of mortality related to PE (<a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>). </p> </section> <section id="CD013422-sec-0074"> <h6 class="title">Post‐thrombotic syndrome</h6> <p>There were no reports of PTS (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>; <a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>). </p> </section> <section id="CD013422-sec-0075"> <h6 class="title">Resolution of symptoms</h6> <p>There were no reports of resolution of symptoms (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>; <a href="./references#CD013422-bbs2-0005" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. [DOI: 10.1161/01.CIR.103.20.2453] ">Pinede 2001</a>; <a href="./references#CD013422-bbs2-0007" title="SchulmanS , RhedinA , LindmarkerP , CarlssonA , LafrarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013422-sec-0076" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013422-sec-0076"></div> <section id="CD013422-sec-0077"> <h3 class="title" id="CD013422-sec-0077">Summary of main results</h3> <p>Our review has demonstrated that in people with distal DVT compared with no anticoagulation or placebo, anticoagulation reduces the risk of VTE recurrence. The results showed a clear effect for a three‐month course of anticoagulation, but not for a treatment lasting up to six weeks, likely as a result of a type II error due to the small number of events, or it may represent a true difference between a shorter or longer course of therapy. There were similar results for the outcome measure of recurrence of DVT, while there was no clear effect on risk of PE, again, likely as a result of a type II error. This benefit was obtained at the expense of clinically relevant non‐major bleeding, but not major bleeding. In a direct comparison of treatment duration, anticoagulation for three months or more was superior to a shorter course lasting up to six weeks, in terms of reduced risk for recurrence of VTE and DVT with no clear difference in major bleeding and clinically relevant non‐major bleeding. </p> </section> <section id="CD013422-sec-0078"> <h3 class="title" id="CD013422-sec-0078">Overall completeness and applicability of evidence</h3> <p>The number of VTE events, as clearly shown in the corresponding forest plots, is relatively small and this may prompt further trials. However, the magnitude and direction of the effect is consistent in the subgroup of <a href="./references#CD013422-fig-0004" title="">Analysis 1.1</a>, but also in <a href="./references#CD013422-fig-0013" title="">Analysis 2.1</a>, suggesting that three months of anticoagulation may be more beneficial than a course of shorter duration. </p> <p>Furthermore, most RCTs included in this review excluded recurrent and cancer‐associated distal DVT, which makes any extrapolation to these groups unsafe; in view of the high‐risk nature of these groups, it is plausible to accept that a minimum of three months of anticoagulation, if not longer, would be also required in these high‐risk situations. Certainly, RCTs on extended treatment (secondary prevention) would be required, ideally testing VKAs and DOACs in prophylactic and therapeutic doses, against placebo. Therapies associated with a low risk for bleeding, such as the prophylactic dose of DOACs may well be tested in secondary prevention of other distal DVTs thought to be high‐risk conditions, such as unprovoked DVT. </p> <p>All but one RCT used a VKA in the investigational arm (following an initial course of heparin), which has the implication that our results apply only to this type of anticoagulant. Further RCTs with LMWHs or DOACs are required. </p> <p>One of the included studies gave anticoagulation for 10 days only (<a href="./references#CD013422-bbs2-0008" title="SchwarzT , BuschmannL , BeyerJ , HalbritterK , RastanA , SchellongS . Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. Journal of Vascular Surgery2010;52(5):1246‐50. [DOI: 10.1016/j.jvs.2010.05.094] ">Schwarz 2010</a>), while the remainder of the studies used anticoagulation treatment for six weeks or more. </p> <p>This review identified no studies using compression for the treatment of distal DVT. RCTs using compression would be required to make a statement regarding this intervention as either a stand‐alone treatment or adjunct to anticoagulant therapy. </p> <p>Finally, our findings may not apply to people with single vein postoperative distal DVT in view of the findings of one RCT included in this review (<a href="./references#CD013422-bbs2-0001" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG . Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57:418‐23. ">Ferrara 2006</a>), where there was no benefit of a three‐month course compared with the shorter six‐week course. The same may also apply to people with thrombosis limited in extent to the soleal or gastrocnemius veins, pending confirmatory results. </p> </section> <section id="CD013422-sec-0079"> <h3 class="title" id="CD013422-sec-0079">Quality of the evidence</h3> <p>See <a href="./full#CD013422-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD013422-tbl-0002">summary of findings Table 2</a>. </p> <p>We observed a low risk of bias for most attributes, with the exception of blinding of participants and personnel (performance bias) due to the open‐label design of most RCTs. Nevertheless, the results of the present meta‐analysis update are generally consistent with a low amount of heterogeneity in almost all comparisons. However, the inclusion of RCTs only in this review must be viewed as a strong point. </p> <p>Using the GRADE assessment, the certainty of evidence for recurrence of VTE and DVT was high; and for PE was low for the comparison of anticoagulation versus placebo and for the comparison of anticoagulation for six weeks versus three months. </p> <p>The certainty of the evidence for the comparison of anticoagulation versus placebo was low for major bleeding and high for clinically relevant non‐major bleeding. The certainty of the evidence for major bleeding and clinically relevant non‐major bleeding for the comparison of anticoagulation for six weeks versus three months was low.. </p> <p>The certainty of the evidence was downgraded because of imprecision due to small number of events and wide confidence intervals. </p> </section> <section id="CD013422-sec-0080"> <h3 class="title" id="CD013422-sec-0080">Potential biases in the review process</h3> <p>The review authors made a conscious effort to identify all potentially relevant trials for inclusion in the present review. Nevertheless, publication bias still could have limited the validity of our results. </p> <p>This review set out to assess only RCTs. Although five of the eight RCTs were published before 2010, the reporting of the study methodology was mostly adequate. </p> <p>The review assessed recurrence of VTE, defined as DVT recurrence in the calf veins, or progression of DVT to proximal veins (e.g. popliteal or femoral vein) or PE, provided that these were objectively diagnosed with venography or ultrasonography for DVT and pulmonary angiography, computed tomography or V/Q scan for PE, as the primary outcome measure. Recurrence of DVT, which included DVT recurrence in the calf veins or progression of DVT to proximal veins, was included as a secondary outcome measure, but in future updates, data permitting, we will add symptomatic proximal DVT and clinically important VTE (proximal DVT and symptomatic PE) as additional important outcomes. </p> </section> <section id="CD013422-sec-0081"> <h3 class="title" id="CD013422-sec-0081">Agreements and disagreements with other studies or reviews</h3> <p>The results presented here agree with one systematic meta‐analysis of 20 case‐control or cohort studies and RCTs that included 2936 people with calf DVT (<a href="./references#CD013422-bbs2-0036" title="FrancoL , GiustozziM , AgnelliG , BecattiniC . Anticoagulation in patients with isolated distal deep vein thrombosis: a meta‐analysis. Journal of Thrombosis and Haemostasis2017;15(6):1142‐54. ">Franco 2017</a>). <a href="./references#CD013422-bbs2-0036" title="FrancoL , GiustozziM , AgnelliG , BecattiniC . Anticoagulation in patients with isolated distal deep vein thrombosis: a meta‐analysis. Journal of Thrombosis and Haemostasis2017;15(6):1142‐54. ">Franco 2017</a> demonstrated a reduction in recurrent VTE rates in people who received anticoagulation compared to those who did not receive anticoagulation (either therapeutic or prophylactic, odds ratio (OR) 0.50, 95% CI 0.31 to 0.79), without an increase in the risk of major bleeding (OR 0.64, 95% CI 0.15 to 2.73). PE rates were also lower with anticoagulation than in the control group (OR 0.48, 95% CI 0.25 to 0.91; 1997 participants). There was a lower rate of recurrent VTE in people who received more than six weeks of anticoagulation in comparison to those who received six weeks of anticoagulation (OR 0.39, 95% CI 0.17 to 0.90; 4 studies, 1136 participants). In comparison, our meta‐analysis included only RCTs known to provide a higher level of evidence than case‐control studies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013422-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013422-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013422-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013422-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 1 Recurrence of venous thromboembolism (VTE)." data-id="CD013422-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 1 Recurrence of venous thromboembolism (VTE). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 2 Major bleeding." data-id="CD013422-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 2 Major bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 3 Recurrence of deep vein thrombosis (DVT)." data-id="CD013422-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 3 Recurrence of deep vein thrombosis (DVT). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 4 Pulmonary embolism (PE)." data-id="CD013422-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 4 Pulmonary embolism (PE). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 5 Clinically relevant non‐major bleeding." data-id="CD013422-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 5 Clinically relevant non‐major bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 6 Overall mortality." data-id="CD013422-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 6 Overall mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 7 Mortality related to PE." data-id="CD013422-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 7 Mortality related to PE. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 8 Mortality related to major bleeding." data-id="CD013422-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 8 Mortality related to major bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 9 Post‐thrombotic syndrome (PTS)." data-id="CD013422-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Anticoagulant versus no intervention or placebo, Outcome 9 Post‐thrombotic syndrome (PTS). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 1 Recurrence of venous thromboembolism (VTE)." data-id="CD013422-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 1 Recurrence of venous thromboembolism (VTE). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 2 Major bleeding." data-id="CD013422-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 2 Major bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 3 Recurrence of deep vein thrombosis (DVT)." data-id="CD013422-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 3 Recurrence of deep vein thrombosis (DVT). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 4 Pulmonary embolism (PE)." data-id="CD013422-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 4 Pulmonary embolism (PE). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 5 Clinically relevant non‐major bleeding." data-id="CD013422-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 5 Clinically relevant non‐major bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 6 Mortality related to PE." data-id="CD013422-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 6 Mortality related to PE. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013422-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/urn:x-wiley:14651858:media:CD013422:CD013422-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_t/tCD013422-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 7 Mortality related to major bleeding." data-id="CD013422-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA, Outcome 7 Mortality related to major bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/media/CDSR/CD013422/image_n/nCD013422-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013422-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Anticoagulant compared to no intervention or placebo for distal deep vein thrombosis treatment</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Anticoagulant compared to no intervention or placebo for distal DVT treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with distal DVT </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> anticoagulant </p> <p><b>Comparison:</b> no intervention or placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention or placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with anticoagulant</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence of VTE</b> </p> <p>(follow‐up: 3 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.34</b><br/> (0.15 to 0.77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>496<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕</p> <p><b>High</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1000<br/> (14 to 70) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Major bleeding</b><br/> (follow‐up: 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.76</b><br/> (0.13 to 4.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>480<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>8 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000</p> <p>(1 to 38)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence of DVT</b> </p> <p>(follow‐up: 3 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.25</b><br/> (0.10 to 0.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>496<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕</p> <p><b>High</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>79 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000<br/> (8 to 53) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>PE</b> </p> <p>(follow‐up: 3 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.81</b><br/> (0.18 to 3.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>480<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000<br/> (2 to 44) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinically relevant non‐major bleeding</b> </p> <p>(follow‐up: 3 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.34</b><br/> (1.07 to 10.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>322<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕</p> <p><b>High</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>61 per 1000<br/> (19 to 190) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Overall mortality</b><br/> (follow‐up: 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.2</b> </p> <p>(0.13 to 77.69)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>430</p> <p>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 death reported in the anticoagulant group. 0 deaths reported in the no intervention or placebo group. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1000</p> <p>(0 to 0)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality related to PE</b><br/> (follow‐up: 3 months) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>430</p> <p>(3 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 PE‐related deaths reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DVT:</b> deep vein thrombosis; <b>PE:</b> pulmonary embolism; <b>RR:</b> risk ratio; <b>VTE:</b> venous thromboembolism. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level as total number of events was fewer than 300.<br/> <sup>b</sup>Upgraded one level due to large treatment effect.<br/> <sup>c</sup>Downgraded two levels for imprecision due to very few events and 95% CIs include both appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Anticoagulant compared to no intervention or placebo for distal deep vein thrombosis treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013422-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Anticoagulation for three months or more compared to anticoagulation for six weeks for distal deep vein thrombosis treatment</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Anticoagulation for 3 months or more compared to anticoagulation for 6 weeks for distal DVT treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with distal DVT </p> <p><b>Setting:</b> hospital </p> <p><b>Intervention:</b> VKA for ≥ 3 months </p> <p><b>Comparison:</b> VKA for 6 weeks </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with anticoagulation for 6 weeks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with anticoagulation for ≥ 3 months</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence of VTE</b> </p> <p>(follow‐up: 16 weeks to 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.42</b><br/> (0.26 to 0.68) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>736<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕</p> <p><b>High</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>135 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57 per 1000<br/> (35 to 92) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Major bleeding</b> </p> <p>(follow‐up: 16 weeks to 15 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.42</b><br/> (0.36 to 32.35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>389<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000<br/> (2 to 161) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence of DVT</b> </p> <p>(follow‐up: 16 weeks to 15 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.32</b><br/> (0.16 to 0.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>389<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕</p> <p><b>High</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>144 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 1000<br/> (23 to 92) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>PE</b> </p> <p>(follow‐up: 16 weeks to 15 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.05</b><br/> (0.19 to 5.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>389<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000<br/> (2 to 59) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinically relevant non‐major bleeding</b> </p> <p>(follow‐up: 16 weeks to 15 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.76</b><br/> (0.90 to 3.42) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>389<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>60 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105 per 1000<br/> (54 to 204) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The included studies did not report on overall mortality.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality related to PE</b> </p> <p>(follow‐up: 15 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>197</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 included study reported there were no cases of death from PE.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DVT:</b> deep vein thrombosis; <b>PE:</b> pulmonary embolism; <b>RR:</b> risk ratio; <b>VTE:</b> venous thromboembolism. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level as total number of events was fewer than 300.<br/> <sup>b</sup>Upgraded one level due to large treatment effect.<br/> <sup>c</sup>Downgraded two levels for imprecision due to very few events and 95% CIs include both appreciable benefit and appreciable harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Anticoagulation for three months or more compared to anticoagulation for six weeks for distal deep vein thrombosis treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/full#CD013422-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013422-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Anticoagulant versus no intervention or placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence of venous thromboembolism (VTE) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>496</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.15, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 anticoagulation for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.02, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 anticoagulation for up to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.23, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.13, 4.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 anticoagulation for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.01, 4.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 anticoagulation for up to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.20 [0.13, 77.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Recurrence of deep vein thrombosis (DVT) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>496</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.10, 0.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 anticoagulation for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 anticoagulation for up to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.14, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pulmonary embolism (PE) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.18, 3.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 anticoagulation for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.04, 3.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 anticoagulation for up to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.13 [0.20, 23.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Clinically relevant non‐major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.34 [1.07, 10.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 anticoagulation for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.33 [0.66, 8.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 anticoagulation for up to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.59 [0.52, 176.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Overall mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.20 [0.13, 77.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 anticoagulation for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 anticoagulation for up to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.20 [0.13, 77.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mortality related to PE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 anticoagulation for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 anticoagulation for up to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Mortality related to major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 anticoagulation for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 anticoagulation for up to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Post‐thrombotic syndrome (PTS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.58, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Anticoagulant versus no intervention or placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013422-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence of venous thromboembolism (VTE) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>736</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.26, 0.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.42 [0.36, 32.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Recurrence of deep vein thrombosis (DVT) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.16, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pulmonary embolism (PE) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.19, 5.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Clinically relevant non‐major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.90, 3.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mortality related to PE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mortality related to major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Anticoagulant versus any anticoagulant: three months or more of vitamin K antagonist (VKA) versus six weeks of VKA</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013422.pub2/references#CD013422-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013422.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013422-note-0013">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013422-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013422-note-0012">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD013422-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013422-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD013422-note-0008">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD013422-note-0007">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013422-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013422\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013422\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013422\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013422\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013422\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013422.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013422.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013422.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013422.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013422.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714243259"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013422.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714243263"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013422.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d69ee1af5f3cd',t:'MTc0MDcxNDI0My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 